Stay updated on Avelumab and Palbociclib in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab and Palbociclib in Breast Cancer Clinical Trial page.

Latest updates to the Avelumab and Palbociclib in Breast Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry v3.5.4 has been added to the Record History, updating the version list; the previous revision v3.5.3 has been removed from the history.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe page’s footer application/version indicator updates from revision v3.5.2 to v3.5.3, indicating a platform release rather than changes to the clinical trial record itself.SummaryDifference0.1%

- Check43 days agoChange DetectedThe record history now includes revision v3.5.2 and removes revision v3.5.0. This is a metadata update to the history log rather than substantive study information.SummaryDifference0.1%

- Check50 days agoChange DetectedThe PALAVY study record title was updated to 'Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer (PALAVY)'. The update also adds IPDSharing, Study Status, and Study Identification fields, replacing the prior title variant.SummaryDifference0.7%

- Check72 days agoChange DetectedRevision: v3.5.0 was added to the Record History. Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision v3.4.3 was added to the Study Record Versions, and revision v3.4.2 was removed.SummaryDifference0.1%

Stay in the know with updates to Avelumab and Palbociclib in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab and Palbociclib in Breast Cancer Clinical Trial page.